144: Issuer Information

Name of Issuer

Apollomics Inc.

SEC File Number

001-41670

Address of Issuer

989 E. Hillsdale Blvd.
Suite 220
Foster City
CALIFORNIA
94404

Phone

650-209-4055

Name of Person for Whose Account the Securities are To Be Sold

OrbiMed Asia Partners II, L.P.

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Shareholder

144: Securities Information

Title of the Class of Securities To Be Sold

Name and Address of the Broker

Number of Shares or Other Units To Be Sold

Aggregate Market Value

Number of Shares or Other Units Outstanding

Approximate Date of Sale

Name the Securities Exchange

Class A Ordinary Shares

Morgan Stanley
1585 Broadway
New York NY 10036

9515756

11323750.00

89480790

11/27/2023

Nasdaq Stock Market

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class

Date you Acquired

Nature of Acquisition Transaction

Name of Person from Whom Acquired

Is this a Gift?

Date Donor Acquired

Amount of Securities Acquired

Date of Payment

Nature of Payment *

Class A ordinary shares

03/29/2023

Business combination

Issuer

9515756

03/29/2023

Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller

Title of Securities Sold

Date of Sale

Amount of Securities Sold

Gross Proceeds

OrbiMed Asia GP II, L.P.
601 Lexington Ave.
54th Floor
New York NY 10022

Class A ordinary shares

11/16/2023

6700000

8375000.00

144: Remarks and Signature

Remarks

OrbiMed Asia GP II, L.P. is the general partner of OrbiMed Asia Partners II, L.P., and OrbiMed Advisors II Limited is the genernal partner of OrbiMed Asia GP II, L.P. OrbiMed Advisors LLC is the advisory company of OrbiMed Asia Partners II, L.P.

Date of Notice

11/27/2023

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Douglas Coon, Chief Compliance Officer, OrbiMed Advisors II Limited, general partner of the general partner of OrbiMed Asia Partners II, L.P.

144: Filer Information

Submission Contact Information